Stock Market News — October 19, 2026 — Morning Update — Last 12 Hours (Pacific Time)
Executive Summary
U.S. markets staged a broad rebound Monday, with the S&P 500 rising and the Nasdaq jumping 1.5% as dip buyers flooded back into AI and semiconductor stocks following their worst week since June. The dominant narrative is a tug-of-war between recovering U.S. tech sentiment and deteriorating European markets, where French civil unrest triggered the CAC 40's worst single-day drop in nearly two weeks and dragged down indices across the continent. Eyes now turn to a heavy earnings week headlined by Meta, Tesla, and SpaceX.
Sentiment Breakdown
| Sentiment | Count | Percentage |
|---|---|---|
| 🟢 Bullish | 98 | 45% |
| 🔴 Bearish | 89 | 40% |
| 🟡 Neutral | 33 | 15% |
Net Sentiment: Cautiously Bullish — U.S. AI/tech bounce and a wave of positive analyst upgrades tip the balance, but European political turmoil, Indonesian market panic, and lingering macro concerns keep the bulls from running free.
Top Market-Moving Headlines
🟢 U.S. Equities | S&P 500 rises and Nasdaq jumps 1.5%, rebounding after their worst week since June
Market Impact: AI-linked stocks led the recovery as dip buyers returned en masse. Morgan Stanley's Michael Wilson flagged the correction may be nearing its end.
🔴 European Equities | European stocks drop amid political turmoil in France; CAC 40 down 1.11%, DAX down 1.24%, IBEX 35 down 1.49%
Market Impact: French civil unrest and weekend riots triggered broad European selling, with French assets suffering their worst session in nearly two weeks. Italy and Spain bore the steepest losses.
🔴 Emerging Markets | 'Panic' selling hits Indonesian markets on MSCI expulsion threat; IDX Composite down 4.02% to six-year low
Market Impact: Fears of a potential MSCI index downgrade sparked a disorderly selloff, with the Jakarta Composite touching levels not seen in six years.
🟢 M&A / Biotech | Silence Therapeutics stock soars 125% on Merck acquisition
Market Impact: Merck's acquisition of Silence Therapeutics sent shares surging over 125%, one of the largest single-day biotech moves of the session.
🟢 Biotech | Disc Medicine surges ~60% on positive Phase 3 trial for rare sunlight disorder
Market Impact: Overwhelmingly positive Phase 3 APOLLO trial results for its lead candidate drove one of the session's biggest percentage gainers.
🔴 Biotech | EyePoint crashes 82% as pivotal wet AMD trial fails, prompting 53% workforce cut
Market Impact: A catastrophic clinical failure wiped out the vast majority of EyePoint's market value; the company simultaneously announced deep layoffs.
🟢 Steel / Earnings | Cleveland-Cliffs surges ~15.5% after Q3 earnings beat
Market Impact: A strong third-quarter earnings beat drove CLF to $14.01, with options activity spiking post-announcement.
🟢 AI Infrastructure | CoreWeave jumps ~6.3% as Goldman Sachs upgrades stock after 25% rout
Market Impact: Goldman's upgrade following a steep correction sparked a sympathy rally across AI infrastructure peers including Nebius and IREN.
🟢 Semiconductors | AI chip startup Tenstorrent raises $1.5 billion at $6.2 billion valuation, more than doubling its prior valuation
Market Impact: The late-stage funding round signals continued private-market conviction in AI chip alternatives despite public-market volatility.
🟢 Amazon / Cloud | Morgan Stanley names Amazon "Top Pick," raises price target to $350 from $335; stock rallies 3.4% to $258.45
Market Impact: AWS strength cited as the key driver; the upgrade added momentum to the broader tech rebound.
🟢 Intel | JPMorgan upgrades Intel to Neutral from Underweight, citing solid execution under CEO Tan; stock rallies ~4%
Market Impact: A long-awaited upgrade from a bearish house signals improving sentiment around Intel's turnaround story.
🟢 Tesla | Tesla climbs 3.1% to $365.59 after proxy filing; shareholders asked to re-elect Musk, Denholm, and Straubel at December annual meeting
Market Impact: The proxy filing ahead of this week's Q3 earnings report added a catalyst; SpaceX/Tesla earnings are set to test Musk's AI spending ambitions.
🟢 Semiconductors | Nvidia wins CPU business from Modal AI startup, previously exclusive to AMD and Intel
Market Impact: Nvidia's expansion into central processors at a fast-growing AI cloud startup signals a broadening competitive threat to AMD and Intel.
🔴 Microsoft | Microsoft pulls out of UK Nscale data centre deal over power delay
Market Impact: The withdrawal from the Nvidia-backed Nscale flagship data centre highlights power availability as a growing constraint on AI infrastructure buildout.
🟢 Pharma / Biotech | Eli Lilly strikes drug-delivery deal with Metis TechBio worth up to $1.1 billion
Market Impact: The collaboration agreement underscores Lilly's continued aggressive dealmaking in next-generation drug delivery technologies.
🔴 Barclays / UK Banking | Bank of England probes Barclays' handling of private credit risks; stock slides 2%
Market Impact: The FT-reported BoE investigation into potential misrepresentation of illiquid private credit loans adds regulatory risk to UK bank sentiment.
🔴 KKR | KKR charged with misleading EU regulators over Telecom Italia network deal; faces potential fine
Market Impact: EU antitrust charges for alleged misleading information during the 2024 review introduce meaningful legal and financial risk for KKR.
🟢 Silgan Holdings | Silgan surges 5.5% on $3.4 billion Trivium acquisition deal
Market Impact: The landmark packaging sector deal signals consolidation appetite remains strong despite broader market volatility.
🟢 MKS / TTM Technologies | MKS to sell Ophir Optics unit to TTM Technologies for $650 million; both stocks rise
Market Impact: TTM gains a high-value optics business while MKS streamlines its portfolio; TTM shares rose 4.2%.
🔴 Apple / iPhone | Jefferies says iPhone 18 demand weakness is "intensifying"; Apple forms double top near $348 ATH resistance
Market Impact: Worsening demand signals for the iPhone 18 Pro and Pro Max add a near-term overhang to Apple's stock despite its $5 trillion market cap milestone.
Tickers in Focus
| Ticker | Price / Change | Context |
|---|---|---|
| CLF | $14.01 / +15.55% | Q3 earnings beat; heavy options activity |
| EVAX | +21.6% | 3-year melanoma vaccine trial data |
| AMP | -3.6% | BofA double-downgrade on advisor attrition |
| GLBE | +2.1% | Morgan Stanley upgrade on growth durability |
| MTCH | +3.4% | Evercore ISI upgrade on Tinder recovery |
| AC (Air Canada) | C$21.34 / -3.0% | Jefferies downgrade |
| PLTR | +3.9% | New partnership announced |
| MU | +4.2% | Dip buyers return to semiconductors |
| TSLA | $365.59 / +3.1% | Proxy filing; Q3 earnings ahead |
| SPCX | +2.6% | Musk pledges one share to every U.S. child; Q3 earnings ahead |
| AMZN | $258.45 / +3.4% | Morgan Stanley "Top Pick," PT raised to $350 |
| NVDA | — | CPU win at Modal; stuck below 200 SMA |
| INTC | ~+4.0% | JPMorgan upgrade to Neutral |
| CRWV | +6.3% | Goldman Sachs upgrade after 25% rout |
| NBIS | +3.6% | Dip buyers return to AI infrastructure |
| IREN | +5.4% | Sympathy rally on CoreWeave upgrade |
| APLD | +8.0% | Insider share purchases disclosed |
| MSFT | — | Pulled out of UK Nscale data centre deal |
| META | $696.74 / -1.8% | Defensive positioning ahead of earnings |
| EYPT | -82% / ~$0.551 | Pivotal wet AMD trial failure; 53% workforce cut |
| IRON (Disc Medicine) | +58.6–60% | Positive Phase 3 APOLLO trial |
| SLN (Silence Therapeutics) | +125.6% | Merck acquisition |
| MANE (Veradermics) | +6.7–6.9% | Phase 3 hair loss drug meets goals |
| SLGN | +5.5% | $3.4B Trivium acquisition |
| MKSI | — | Selling Ophir Optics to TTM for $650M |
| TTWO | — | GTA VI release analysis |
| EOSE | +2.5% | Preliminary Q3 revenue beats estimates |
| LEU (Centrus Energy) | +4.0% | Acquired Westerman for $116M |
| XNDU | +3.0% | DARPA contract approval |
| ASTS | +3.9% | European broadband push |
| DDOG | +3.6% | Bernstein upgrade to Outperform |
| WDC (Western Digital) | +6.7% | Upgraded to "Strong-Buy" |
| SNDK (SanDisk) | +7.5% / $1,397.35 | Bounce from selloff lows |
| SK Hynix | $143.05 / +4.8% | Supply chain report catalyst |
| Seagate | $660.78 / +3.4% | Broad semiconductor recovery |
| Marvell | +3.6% | Bounce from Friday sell-off |
| Moderna | $227.50 / +4.4% | Sector rotation into biotech |
| Nidec | ¥1,749 (decade low) | Execs found liable in accounting scandal |
| Vonovia | €16.55 / -1.7–2.6% | Berlin coalition expropriation report |
| Lindt | CHF 8,315 / -1.3% | CEO Lechner departure announced |
| Barclays | 424.2p / -2.0% | BoE private credit probe |
| KKR | — | EU antitrust charges over Telecom Italia deal |
| Euronext | €170.2 / +1.8% | Citi upgrade; 52-week high |
| Steyr Motors | +~20% | Red Cat tender offer |
| BIST 100 | -2.49% | Turkey broad market decline |
| IDX Composite | 4,921.74 / -4.02–5.1% | MSCI expulsion threat; six-year low |
Market Implications
The U.S. tech rebound on Monday looks encouraging on the surface, but the technical picture remains fragile. The Nasdaq 100 is still trapped below the 30,101 level following its all-time high breakdown, NVIDIA is stuck below its 200-day moving average, and the S&P 500's double-top formation near recent highs suggests the bounce could face resistance before a sustained recovery. With Meta, Tesla, and SpaceX all reporting earnings this week, the market's next directional move will likely be determined by whether AI spending guidance holds up under scrutiny — particularly given S&P Global's warning that hyperscaler AI-linked debt may be larger than currently disclosed.
Europe is a separate and more acute concern. French civil unrest has moved beyond a local story — it's now a political risk premium event for European assets broadly, with the CAC 40, DAX, IBEX 35, and Italy 40 all closing meaningfully lower. The Bank of England's probe into Barclays and KKR's EU antitrust charges add regulatory noise to an already stressed European financial sector. Investors rotating out of European equities may find a temporary home in U.S. tech, but that trade depends heavily on this week's earnings delivering.
The most underappreciated risk signal of the session may be Indonesia. A potential MSCI index expulsion triggered panic selling that pushed the Jakarta Composite to a six-year low — a reminder that emerging market contagion can move fast when index inclusion is threatened. Separately, the record $7 billion inflow into the Direxion Daily Semiconductor Bull 3X ETF during last week's selloff is a double-edged signal: it shows retail conviction in the AI trade, but also flags the kind of leveraged positioning that can amplify volatility in both directions if earnings disappoint.
Key Takeaways
- 🟢 Nasdaq +1.5% — Biggest single-day bounce after the worst week since June; AI dip buyers showed up in force.
- 🔴 France riots — Weekend civil unrest drove CAC 40 to its worst session in nearly two weeks; European-wide contagion followed.
- 🔴 Indonesia IDX -4–5% — MSCI expulsion threat triggered panic selling to a six-year low; watch for EM contagion signals.
- 🟢 Silence Therapeutics +125% — Merck acquisition is the session's biggest M&A move; validates RNA-interference drug delivery.
- 🔴 EyePoint -82% — Pivotal wet AMD trial failure plus 53% workforce cut; a cautionary tale on binary clinical risk.
- 🟢 Disc Medicine +60% — Positive Phase 3 data for rare sunlight disorder; one of the session's strongest biotech catalysts.
- 🟢 Cleveland-Cliffs +15.5% — Q3 earnings beat drives the steel sector's standout move of the day.
- 🟢 CoreWeave +6.3% — Goldman upgrade after a 25% rout sparked a broad AI infrastructure sympathy rally.
- 🟢 Amazon named Morgan Stanley "Top Pick" — PT raised to $350; AWS strength is the thesis; stock up 3.4%.
- 🟢 Intel upgraded by JPMorgan — Shift from Underweight to Neutral signals the bear case is fading under CEO Tan.
- 🟢 Tenstorrent raises $1.5B at $6.2B valuation — Private AI chip market still attracting massive capital despite public-market volatility.
- 🔴 Microsoft exits UK Nscale data centre deal — Power availability delays are becoming a real brake on AI infrastructure expansion.
- 🔴 KKR faces EU antitrust charges — Alleged misleading information in the Telecom Italia deal; potential fine adds headline risk.
- 🔴 Barclays under BoE probe — Private credit misrepresentation investigation adds regulatory overhang to UK banks.
- 🟢 Silgan +5.5% on $3.4B Trivium deal — Packaging sector M&A signals industrial consolidation appetite remains alive.
- 🔴 Apple iPhone 18 demand "intensifying" weakness — Jefferies warning adds near-term pressure despite $5T market cap milestone.
- 🟢 Nvidia wins CPU business at Modal — Expanding beyond GPUs into central processors at AI startups is a strategic escalation.
- 🟢 Amazon AI chips challenge Nvidia — New tool enabling custom chips to run popular coding languages broadens competitive landscape.
- 🔴 Nidec hits decade low — Accounting scandal liability findings continue to weigh; no clear floor yet.
- 🟡 Tesla/SpaceX earnings this week — Musk's AI spending ambitions and merger speculation will be tested; proxy filing adds shareholder governance angle.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Insider transactions can have many motivations beyond stock outlook.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/